Exposure of type III collagen coats on plastic cover slips In parallel-plate perfuslon chambers to flowing nonanticoagulated human blood resulted In deposition of platelets and fibrin. Blood was drawn directly from an antecubltal vein by an occluslve roller pump over the collagen coats In chambers having flow silts of different dimensions, so that wall shear rates of 100,650, and 2600 s~1 were obtained at 10 ml/mln. Coagulation was minimally activated during the passage of blood from the vein to the chamber as shown by fibrlnopeptlde A levels of 3.7 ng/ml after 5-mlnute perfuslons. The surface coverage with platelets increased from 18% at 100 s" 1 to 59% at 2600 s \ and the corresponding thrombus volumes Increased from 2 to 22 fim'/fim', respectively. This contrasted with the coverage with fibrin on collagen, which decreased from 28% at 100 s 1 to 9% at 2600 s~1. Fibrin deposits on the thrombi covered 6% of the surface irrespective of the shear rate, Indicating that some of the deposited platelets accelerated the deposition of fibrin. The type III collagen preparation did not activate factor XII and did not possess tissue factor activity, Indicating that the surface Itself was not procoagulant However, a correlation between deposited leukocytes and surface coverage with fibrin was observed ( T he component of the vessel wall that most potently triggers the formation and growth of thrombi is considered to be collagen.
T he component of the vessel wall that most potently triggers the formation and growth of thrombi is considered to be collagen. 1 -2 So far, 13 species of collagen have been identified, and many have been localized in the vessel wall. 3 ' 4 One of these is type III collagen, which is synthesized by endothelial cells 6 and is present in subendothelium. Type III collagen binds platelets and builds up thrombi when exposed to flowing citrated blood. 87 Furthermore, in fibrillar form It triggers platelet aggregation when added to stirring platelet-rich plasma. 8 However, controversy exists as to whether collagens are able to initiate coagulation through activation of coagulation factor XII 9 1 0 1 1 and thereby amplify its thrombogenic potential. Activation of factor XII leads to generation of thrombin and fibrin, which respectively reinforce growth and stability of thrombi. 12 -
The interactions between nonanticoagulated blood and type III collagen have not yet been studied. Since type III collagen is one of the most abundant collagens in subendothelium, 17 and as such may become exposed to blood at the sites of vascular injury, we decided to expose surfaces coated with fibrillar human type III collagen to flowing nonanticoagulated blood under controlled conditions. The blood flow conditions mimicked those in large veins, middle-sized and small arteries, and stenosed arteries. Particular emphasis was placed on the effect of the shear rate on the thrombus dimensions and on the interactions between platelets and collagen, platelets and fibrin, and collagen and fibrin, and on the deposition of leukocytes. The formation of fibrin may originate from coagulation initiated through tissue factor and factor X by deposited monocytes, 1819 through activation of factor XII by the collagen coat, 10 or by both mechanisms.
Methods

Perfuslon Chambers
A number of different perfuslon chambers for the study of platelet-surface interactions in vitro and ex vivo have been designed. 2021 - 22 In parallel-plate perfusion chambers, 21 -22 the blood enters and leaves the chamber through tubings; thus, the geometry of the flow channel is changed from circular to rectangular and vice versa, a transition that is usually accompanied by a change in cross-sectional area. Such transitions may lead to unsteady flow or flow separation in the chamber. We designed three parallel-plate perfusion chambers according to the original model of Sakariassen et al, 22 but with smooth transitions from the circular to the rectangular cross-sectional profile ( Figure 1A ) and vice versa. The length (x) of the parallel-plate center piece is 120 mm in all cases, with the cover slip positioned 70 mm downstream from the flow inlet of the center piece. Width (y) and height (z) vary and are: 8x1.173 (Chamber C), 8x0.446 (Chamber B), and 5x0.282 mm (Chamber A) for wall shear rates of 100, 650, and 2600 s~\ respectively, at a blood flow rate of 10 ml/min. Inlets and outlets are all 20 mm long and circular (radius=0.7 mm). The transitions from the inlet to the parallel-plate center piece and from the center piece to the outlet are all 50 mm long; the transition profiles in the x,y and x,z planes are sinusoidal half-waves ( Figure 1B ). The rest of the profile was computed by computer-assisted design. Calculations showed that a reduction of the pressure gradient due to the decrease of kinetic energy was less than 5% of the prevailing viscous force, indicating laminar flow conditions in the chamber. These chambers allow studies with citrated and nonanticoagulated blood under defined fluid dynamic conditions. Different venous and arterial shear rates can be maintained without introducing gross changes in other variables of importance, such as blood flow rate and transit time, the time needed for blood to flow from an antecubital vein to the cover slip in the chamber. Two additional chambers (D and 1) were designed for some studies with citrated blood. The dimensions and physical parameters of all chambers are summarized in Table 1 .
Purification and Characterization of Type III Collagen
Human type III collagen was purified from a lyophilized human placental pepsin extraction by selective salt precipitation. 23 The final preparation appeared more than 95% pure as judged by sodium dodecyl sulfatepolyacrylamide electrophoresis and densitometry scanning. Fibrils were made by dialysis for 48 hours against 20 mM of Na 2 HPO 4 , pH 7.4, 24 and the collagen concentration was measured by hydroxyproline assay. 25 The final preparation (up to 700 ^g/ml) had no detectable tissue factor activity as measured by a one-stage prothrombin time clotting assay 26 utilizing 1 to 100 /K)/ml of rat thromboplastin (Diagen, Diagnostic Reagents, Thame, Oxon, UK) as a reference curve. The preparation was not able to activate coagulation factor XII in the presence of phospholipid in a modified one-stage partial thromboplastin time clotting assay. 11 The detection limit was < 1 % of plasma factor XII based on a reference curve with factor Xll-deficient substrate plasma (Behring Werke AG, Frankfurt, FRG).
Preparation of Reactive Surfaces
Blood-surface interactions were studied with three surfaces: 1) Thermanox plastic cover slips (Miles Laboratories, Naperville, IL) washed with ethanol (100%); 2) purified type III fibrillar collagen coated on Thermanox; and 3) collagen coats incubated with a monoclonal antibody (MAb) directed against tissue factor. Washed Thermanox cover slips were spray-coated with 0.7 to 1.0 mg/ml of fibrillar collagen with an airbrush (Model 1001, Badger Airbrush, Franklin Park, IL) at a nitrogen operating pressure of 1 atm to a final density of about 20 Mg/cm 2 , as previously described. 2122 Electron microscopic investigation (Philips EM 300 microscope) of the collagen coat revealed a homogeneous meshwork of fibrils with a coat thickness of 2.5±1.2 /xm (mean±SE, n=15). A purified monoclonal antibody, MAb HTF1-TB8, 27 kindly provided by Yale Nemerson, was pre-incubated at 100 ^g/ml in 0.2 M Tris-HCI buffer (pH=7.4) with cover slips coated with collagen at 22°C for 20 minutes. The collagen coat was rinsed with the Tris-HCI buffer 28 and was successively used in perfusion experiments. MAb HTF1-TB8 is monospecific for human tissue factor and neutralizes tissue factor initiated coagulation. Control collagen coats were incubated with 0.2 M Tris-HCI at 22°C for 20 minutes.
Perfusions
Perfusions were carried out with: 1) nonanticoagulated blood drawn directly from an antecubital vein over the surfaces by an occlusive roller pump and 2) blood anticoagulated with citrate, which was recirculated over the surfaces. 202930 Blood was taken from healthy volunteers who stated that they had not taken any medication in the 10 days before the donations. Platelet count and hematocrit ranged within 1.5 to 3.1 x 10 11 /l and 40% to 51 %, respectively. Fibrinopeptide A (FPA) levels in nonanticoagulated blood at the flow inlet of the chamber after perfusion of blood for 5 minutes at 10 ml/min were measured by an ELJSA kit purchased from Boehringer-Mannheim, Mannheim, FRG. The assay is indicative for active thrombin. 
Nonanticoagulated Blood
Nonanticoagulated blood was drawn over the surfaces for 5 minutes at shear rates of 100, 650, and 2600 s~\ Flow rates varied from 2.5 to 10.0 m|/min as indicated in Tables 1 and 2 and in the figure legends. Postperfusion was carried out for 20 seconds with buffer consisting of 130 mM NaCI, 2 mM KCI, 12 mM NaHCQ,, 2.5 mM CaC^, 0.9 mM MgCIa and 5 mM glucose (pH 7.4), immediately after the perfusbn with Wood and at the same shear rate, avoiding blood-air interphase through the use of a T-piece shunt Subsequently, fixative (2.5% glutaraWehyde in 0.1 M of cacodylate, pH 7.4) was perfused for 40 seconds at the same shear rate, followed by removal of the cover slip from the chamber and immersion into freshly prepared fixative. The specimens were finally embedded in Epon. 30 Occasionally technical problems occurred which caused air bubbles in the perfusion system during perfusion with blood and during perfusion with buffer/fixative. Such situations led generally to increased deposition of fibrin, and these cover slips were discarded.
Cltrated Blood
Crtrated blood was antJcoagulated with 1M0 vol of 108 mM trisodium citrate, and the plasma citrate concentration was adjusted to 20 mM by adding 108 mM of trisodium citrate depending on the hematocrit. The perfusate was redrculated for 5 minutes at shear rates of 100, 650, and 2600 s" 1 and at flow rates varying from 2.5 to 65.0 ml/min as indicated in Tables 1 and 2 and in the figure legends. Postperfusion and fixation were carried out as described above.
Morphometry
Semi-thin sections for light microscopic morphometry of platelet-surface and fibrin-surface interactions were prepared from Epon-embedded preparations at an axial position of 1 mm downstream from the flow inlet at the cover slip and perpendicular to the direction of the blood flow. 30 The interactions were assessed by standard morphometry 12 and computer-assisted morphometry.
12^0
Standard Morphometry
Standard morphometry was used to quantify the percent surface coverage of: 1) platelets not spread out on the surface (%C) and platelets spread out on the surface (%S), 2) thrombi more than 5 Aim in height, and 3) fibrin on collagen and on platelets. 15 The various interactions were quantified at 10 ^m intervals by moving an eyepiece micrometer positioned in the ocular along the surface, resulting in approximately 400 determinations at so-called intersection points. The sum of %C+%S represents the total platelet adhesion, which is expressed as percent surface coverage with platelets. Fibrin fibrils are recognized in sections cut perpendicular to the blood flow as circular spots associated with collagen, platelets, or leukocytes (see Figure 5A ). Percent surface coverage with fibrin on collagen or on platelets was determined according to the number of intersection points with fibrin on collagen or on platelets relative to the total intersection points evaluated. Normalization of percent coverage with fibrin on platelets and collagen, respectively, was calculated according to the formulas: 100% x percent fibrin on platelets/percent (C+S) and: 100% x percent fibrin on collagen/percent collagen surface not covered with platelets
In addition, all leukocytes in a section were counted and expressed as number of leukocytes per 100 i±m of sectional length.
Computer-assisted Morphometry
Computer-assisted morphometry (IBM computer and DIASYS program, Heinz Meyer, DataLab, Thdrigen, Switzer- land) was used to quantify: 1) thrombus density (number of thrombi more than 2.5 fim in height/100 /un sectional length, 2) average thrombus height (jun), and 3) thrombus area (jiitfliim sectional length). Thrombus volume (^mV/im 2 ) was derived from the sectional thrombus area.
-30
Statistical Analysis
The results were expressed as means±SD and means±SE. The p values (<0.05) were considered significant and were based on Student's t test. The power curve fit, according to the formula: 
Results
Blood-Collagen Interactions: Effect of Shear Rate and Citrate
The effect of in vitro anticoagulation with trisodium citrate on the deposition of platelets and fibrin on collagen was investigated at wall shear rates of 100, 650, and 2600 s"
1 . Shear rate dependency of the average percent surface coverage with platelets was similar in nonanticoaguiated and in citrated blood (Figure 2A ). The thrombus density was significantly higher in anticoagulated blood (Figure 2B) . The thrombus height and thrombus volume increased dramatically with increasing shear rates in nonanticoaguiated blood, but much less in citrated blood. SignificantJy higher values for thrombus height and thrombus volume in nonanticoaguiated blood were observed at all shear rates ( Figures 2C and 2D) .
Deposition of fibrin on collagen and platelets was observed in nonanticoaguiated blood only. An inverse relationship between fibrin deposition on collagen and increasing shear rate was present while the deposition on the platetets remained constant ( Figure 3A) . However, when the fibrin deposition on platelets was normalized relative to the surface coverage with platelets, the deposition decreased with increasing shear rate, yielding 41 % at 100 s" 1 , 11% at 650 s -\ and 10% at 2600 s" 1 ( Figure 3B ). Deposition of fibrin on collagen also decreased with increasing shear rate when the fibrin was normalized ( Figure 3B ), although much less than the fibrin deposition on platelets.
Donor-related variation of surface coverage with fibrin on collagen at 100 s~1 shear rate was large, and ranged from 1 % to 69%. A correlation between deposited leukocytes and surface coverage with fibrin was observed (Figure 4) . Deposition of leukocytes at shear rates of 650 s" 1 and 2600 s" 1 was rare and was virtually absent at any of the three shear rates in citrated blood.
Pre-incubation of the collagen coat with MAb HTF1-TB8 did not significantly inhibit the deposition of fibrin on collagen. The surface coverage of fibrin on collagen of 21.5±8.1% and 9.3±4.6% (means±SE, n=5 to 6) were measured on coats pre-incubated with MAb HTF1-TB8 and Tris-HCI (control coats), respectively. FPA values of 3.7±2.4ng/ml (means±SD, n=11) were measured at the flow inlet of the chambers after 5-minute perfusion at 10 ml/min. The upper limit of the normal range is defined as 3.0 ng/ml. The individual FPA values were not correlated to the corresponding levels of the coverage with fibrin on platelets and collagen.
Representative light micrographs from perfusions of nonanticoagulated blood at 100, 650, and 2600 s~1 are shown in Figure 5 .
Blood-Collagen Interactions: Effect of Flow Rate
The effect of flow rate on platelet-collagen and fibrincollagen interactions was investigated at a 650 s~1 wall shear rate. Increasing the flow rate from 2.5 to 10 ml/min, with corresponding transit times decreasing from 18.5 to 4.5 seconds, did not affect platelet-collagen and fibrincollagen interactions in nonanticoagulated blood (Table 2). Similarly, platelet-collagen interactions in citrated blood were not influenced by increasing the flow rate from 2.5 to 65.0 ml/min (Table 2 ).
Blood-Thermanox Interactions: Effect of Shear Rate and Citrate
The effect of in vitro anticoagulation with trisodium citrate on the deposition of platelets and fibrin on Thermanox cover slips was investigated at wall shear rates of 100, 650, and 2600 s" 1 . Surface coverage with platelets in nonanticoagulated blood increased from 27% (100 s" 1 ) to 51% (650 s~1) but dropped to 15% at the highest shear rate (2600 s~1). Relatively high percentages of the total adherent platelets (%C+%S) were not spread out on the surface (100%x%C/ %[C+S]), averaging 15% at 100 s~\ 7% at 650 s~\ and 22% at 2600 s" 1 . The surface coverage in citrated blood was below 4% and was independent of the shear rate ( Figure 6A ). The platelets appeared poorly spread out on the surface but were merely making contact with the surface by a small portion of the membrane. A few small thrombi were observed in nonanticoagulated blood at 650 and 2600 s" 1 . No thrombi were observed in citrated blood ( Figure 6B) . A higher thrombus volume was measured at 650 s" 1 than at 2600 s~\ but no difference in the corresponding heights were found ( Figures 6C and 6D) . A few small fibrin deposits in nonanticoagulated blood covering less than 2% of the surface were observed at all shear rates. No deposited leukocytes were observed.
Discussion
Thrombin and fibrin accelerate and stabilize growth of platelet plugs and mural thrombi, respectively, at sites of vascular lesions, 12 -1631 - 35 where platelets also interact with collagen fibrils. 2433 A number of studies utilizing anticoagulated blood have focused on platelet-collagen interaction and have thus neglected the importance of coagulation. 6721223036 This led us to investigate the interactions of platelets in nonanticoagulated blood using a well-characterized preparation of fibrillar type III collagen under blood flow conditions mimicking situations in the venous and arterial circulation. For comparison, parallel studies were performed with blood anticoagulated with trisodium citrate. We found a dramatic increase of thrombus dimensions in nonanticoagulated blood, indicating that activated coagulation plays a pivotal role in thrombus growth. The presence of fibrin deposits on collagen and platelets agrees with activated coagulation, although the surface coverage with fibrin was much less than that reported on artery subendothelium. . Light micrographs of platelet-collagen interactions in nonanticoagulated blood after 5-minute perfusion at 10 ml/min flow rate at shear rates of 100 s~1 (A), 650 s~1 (B), and 2600 s~1 (C). A section with an area of deposited fibrin (F) and a leukocyte (L) with a thrombus attached to the fibrin meshwork T-F is shown at 100 s~1. A thrombus with a tunnel-like structure (TV), which apparently was formed from two separately formed thrombi, is shown at 650 s~1. The same phenomenon (TU) is shown at 2600 s'\ The collagen coat is not visible, since the staining procedure does not contrast the fibrils, x 1542.
A new set of modified parailel-plate perfusion chambers was developed for this study. The modifications aimed at minimizing the activation of coagulation during the passage of blood from the vein to the test surface and at conditions where blood-surface interactions could be studied at various shear rates, but constant flow rate. The chambers had: 1) smooth transitions from circular to rectangular crosssections and vice versa, and 2) different dimensions of the parallel-plate flow slit, so that one flow rate (10 ml/min) produced wall shear rates of 100,650, and 2600 s" 1 in three Value are means±SE. The shear rate was 650 s" 1 and was maintained for 5 minutes. N-4 to 6. C=surface coverage with platelets not spread out on the surface, S=surface coverage with platelets spread out on the surface, T=thrombl, n.d.=not determined.
separate chambers with relatively short times (4.5 to 10.5 seconds) for Wood to pass from the vein to the test surface. Activation of coagulation during the blood passage was minimal (FPA levels of -3.7 ng/ml) and did not correlate with the deposition of fibrin on collagen and platelets. Furthermore, the low surface coverage (<2%) with fibrin on uncoated Thermanox cover slips and the unchanged coverage with fibrin on collagen upon prolongarjon of the transit time from 4.5 to 18.0 seconds indicated little activation during the blood passage to the reactive surface as well.
Thrombi prevailed on the collagen coat in contrast to the relatively sparse deposition of fibrin. The kinetics of the platelet-collagen interactions appeared similar to that reported for artery subendothelium.
14 It Is apparent that the shear rate and not the flow rate affected the deposition of platelets and fibrin on collagen, since increasing the flow rate from 2.5 to 10 ml/min at 650 s" 1 shear rate did not affect either deposition. Also, increasing the flow rate from 2.5 to 65.0 ml/min at the same shear rate in citrated blood did not change the deposition of platelets on the collagen.
The low surface coverage with fibrin was apparently due to the lack of tissue factor in the collagen coat, since pre-incubation with MAb HTF1-TB8 did not inhibit the deposition of fibrin, while pre-incubation of the same MAb with subendothelium lowered the deposition of fibrin 38 to levels observed on the collagen surface. Since the collagen preparation possessed no detectable tissue factor and was not able to activate factor XII, the coagulation might have been initiated through expression of tissue factor 18 and/or activation of factor X by monocytes. 38 The significant correlation between the large donor-related variation of fibrin deposition with the deposited leukocytes at 100 s" 1 shear rate may indicate a role for these cells in deposition of fibrin at low shear rates. An unambiguous distinction between neutrophils and monocytes was not possible in the semi-thin sections. Some of these leukocytes may have interacted with the pre-formed fibrin meshwork, but monocytes as well as neutrophils and lymphocytes mediate fibrin deposition. 40 However, induction of coagulation by leukocyte cell lines other than monocytes has not been reported, 41 and previous findings have shown instant expression of procoagulant activity of monocytes after exposure to adenosine djphosphate and thrombin 19 . 39 and within 30 minutes after adhesion to glass, plastic, and cultured endothelial cells. 18 However, formation of tissue factor/F Vila and its catalytic product, FXa, at the site of the venepuncture, followed by translocation of activated coagulation proteins to the cover slip and their subsequent binding to platelets and leukocytes and perhaps to collagen, may have contributed to the fibrin deposition. Acceleration of coagulation by activated platelets, which convert factor X to Xa and prothrombin to thrombin, 15 -4243 apparently contributed to the deposition of fibrin, since substantial deposition of fibrin on the platelet thrombi was observed. The coverage with fibrin on the platelets was inversely related to the shear rate, but the deposition on the platelets, as opposed to that on collagen itself, gradually contributed more to the total surface coverage by increasing shear rate.
The deposition of fibrin on the collagen surface contrasted with the minute deposition of fibrin on Thermanox, despite a relatively high surface coverage with platelets and a few small platelet thrombi. Apparently, little platelet activation had occurred, since activation is a prerequisite for expression of procoagulant activity. 43 The relatively high percentage (7% to 22%) of adherent platelets not spread out on the surface indicates little platelet activation 44 and suggests unstable platelet-Thermanox binding, which may also explain the drop in surface coverage with platelets at the highest shear rate, 2600 s" 1 . However, activation of coagulation at the site of the venepuncture, as discussed above, may have contributed to this minor fibrin deposition, since leukocytes were not observed on the Thermanox. This set of experiments shows, furthermore, the importance of using nonanticoagulated blood at conditions of arterial shear rates to investigate the reactivity of artificial surfaces, since anticoagulation with trisodium citrate caused a dramatic fall in platelet-Thermanox interactions. The reason for this is unclear, but cheiation of divalent cations by citrate may affect the binding of platelets to the surface adsorbed protein layer. Reduced cation levels may also influence the absorption processes and the conformation of the adsorbed proteins, since the quality and the quantity of the adsorbed proteins determine the surface reactivity. 46 On the other hand, locally formed thrombin in nonanticoagulated blood may activate platelets and perhaps improve adhesion through the glycoprotein complex llb-llla in the platelet membrane by binding to deposited fibrinogen, fibrin, fibronectin, and von Willebrand factor.
A second striking feature introduced by anticoagulation with citrate was the reducing effect on the thrombus dimensions, especially at shear rates above 650 s"'. Inhibited formation of thrombin and fibrin in and around the thrombi may account for this. 1 3 1 4 1 8 3 4 However, the higher thrombus density in citrated blood may reflect higher concentration of platelets in the boundary layer, since fewer platelets are consumed by the slower growing thrombi, thus making more platelets available to form new small thrombi. Whether thrombin or other activated coagulation factors affect adhesion of platelets to collagen remains to be established, although our data show similar adhesion in both systems. Unfortunately, the interpretation of this set of data is difficult, since the platelet concentration in the boundary layer varies with the respective kinetics of the thrombus growth. 38 The slower growth in citrated blood yields higher concentrations of platelets in the boundary layer and thus more platelets available to adhere to collagen. On the other hand, rapidly growing thrombi in nonanticoagulated blood induce more pronounced flow disturbances, which may affect the local platelet concentration in the boundary layer, making it impossible to deduce differences in relative platelet densities at the surface.
Nonetheless, the enhanced growth of thrombi in nonanticoagulated human blood is striking and indicates a pivotal role for coagulation in the early phase of arterial thrombogenesis. This assumption is supported by a recent study 16 showing that inactivation of thrombin with a synthetic inhibitor of low molecular weight, D-Phe-ProArgCHjCI, inhibits acute platelet-dependent thrombosis in vascular grafts at arterial shear rates in a nonhuman primate model. The role of leukocytes in initiation and mediation of fibrin deposition in early collagen-induced thrombogenesis appears to be most pronounced at flow regimens of low shear, in contrast to platelets, which appear to mediate deposition of fibrin at all shear rates.
